サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1221074

抗生剤耐性の世界市場：新規抗生剤開発のための研究開発投資の増加が、市場の成長を促進

Increasing Investment in R&D to Develop Novel Antibiotics Spurs Growth in Antibiotic Resistance Market
出版日: | 発行: Persistence Market Research | ページ情報: 英文 272 Pages | 納期: 2～5営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.86円
抗生剤耐性の世界市場：新規抗生剤開発のための研究開発投資の増加が、市場の成長を促進
出版日: 2022年12月30日
発行: Persistence Market Research
ページ情報: 英文 272 Pages
納期: 2～5営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートでは、世界の抗生剤耐性市場を調査し、市場の構造に関する詳細情報とともに、促進要因、動向、機会、抑制要因、競合情勢など、主要な市場力学についての詳細な評価と、2023年から2033年の予測期間中の予測を掲載しています。

目次

第1章 エグゼクティブサマリー

第2章 市場概要

  • 市場範囲/分類法
  • 市場の定義/範囲/制限
  • 包含と除外

第3章 主要な市場動向

  • 市場に影響を与える主要な動向
  • 製品革新・開発動向

第4章 主要な成功要因

  • 疾病疫学
  • 製品採用分析
  • 製品USP分析
  • 採用された主要な戦略：メーカー別
  • パイプライン評価
  • PESTLE分析
  • ポーターの分析
  • 規制シナリオ

第5章 市場の背景

  • マクロ経済要因
    • 世界のGDPの見通し
    • 世界のバイオ医薬品の見通し
  • 予測要因：関連性と影響
    • 主要企業の成長履歴
    • 院内感染の有病率
    • 主要な規制
    • 政府資金
    • 償還ポリシー
    • 研究開発の実践の拡大
    • 細菌感染の発生率
    • 新製品の発売と承認
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会分析

第6章 COVID-19危機

  • 2022年の市場シナリオ
  • COVID-19と影響分析
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路別
    • 地域別

第7章 世界の抗生剤耐性市場：需要分析・予測

  • 過去の市場分析
  • 現在および将来の市場予測
    • 前年比成長動向分析

第8章 世界の抗生剤耐性市場の分析・予測：薬剤クラス別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：医薬品クラス別
  • 現在および将来の市場分析・予測：薬剤クラス別
    • ベータラクタム抗生剤
    • セファロスポリン
    • キノロン系抗生剤
    • マクロライド系抗生剤
    • テトラサイクリン系
    • オキサゾリジノン
    • その他
  • 市場魅力分析：薬剤クラス別

第9章 世界の抗生剤耐性市場の分析・予測：病原体別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：病原体別
  • 現在および将来の市場分析・予測：病原体別
    • 黄色ブドウ球菌
    • 肺炎連鎖球菌
    • 淋菌
    • エンテロコッカス・フェシウム
    • 大腸菌
    • クレブシエラ肺炎
    • シゲラ
    • クロストリジウム・ディフィシル
    • その他
  • 市場魅力分析：病原体別

第10章 世界の抗生剤耐性市場の分析・予測：疾患別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：疾患別
  • 現在および将来の市場分析・予測：疾患別
    • 市中感染性細菌性肺炎（CABP）
    • 院内細菌性肺炎/人工呼吸器（HABP/VABP）
    • 複雑性尿路感染症（CUTI）
    • 複雑性腹腔内感染症（CIAI）
    • 血流感染症（BSI）
    • 腹部感染症・下痢症（クロストリジウム・ディフィシル感染症（CDI）および赤痢菌）
    • 急性細菌性皮膚・皮膚構造感染症（ABSSSI）
    • 薬剤耐性淋菌
  • 市場魅力分析：疾患別

第11章 世界の抗生剤耐性市場の分析・予測：作用機序別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：作用機序別
  • 現在および将来の市場分析・予測：作用機序別
    • 細胞壁合成阻害剤
    • タンパク質合成阻害剤
    • DNA合成阻害剤
    • RNA合成阻害剤
    • その他
  • 市場魅力分析：作用機序別

第12章 世界の抗生剤耐性市場の分析・予測：流通チャネル別

  • イントロダクション/主要な調査結果
  • 過去の市場分析：流通チャネル別
  • 現在および将来の市場分析・予測：流通チャネル別
    • 病院薬局
    • 小売薬局
    • オンライン薬局
  • 市場魅力分析：流通チャネル別

第13章 世界の抗生剤耐性市場の分析・予測：地域別

  • イントロダクション
  • 過去の市場分析：地域別
  • 現在の市場分析・予測：地域別
    • 北米
    • ラテンアメリカ
    • 欧州
    • 東アジア
    • 南アジア
    • オセアニア
    • 中東・アフリカ
  • 市場魅力分析：地域別

第14章 北米の抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • 米国の抗生剤耐性市場
    • カナダの抗生剤耐性市場

第15章 ラテンアメリカの抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • ブラジルの抗生剤耐性市場
    • アルゼンチンの抗生剤耐性市場
    • メキシコの抗生剤耐性市場

第16章 欧州の抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • ドイツの抗生剤耐性市場
    • フランスの抗生剤耐性市場
    • イタリアの抗生剤耐性市場
    • スペインの抗生剤耐性市場
    • 英国の抗生剤耐性市場
    • ベネルクス諸国の抗生剤耐性市場
    • ロシアの抗生剤耐性市場

第17章 南アジアの抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • インドの抗生剤耐性市場
    • インドネシアの抗生剤耐性市場
    • マレーシアの抗生剤耐性市場
    • タイの抗生剤耐性市場

第18章 東アジアの抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • 中国の抗生剤耐性市場
    • 日本の抗生剤耐性市場
    • 韓国の抗生剤耐性市場

第19章 オセアニアの抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • オーストラリアの抗生剤耐性市場
    • ニュージーランドの抗生剤耐性市場

第20章 中東・アフリカの抗生剤耐性市場：分析・予測

  • イントロダクション
  • 過去の市場動向分析：市場分類別
  • 現在および将来の市場分析・予測：市場分類別
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 市場魅力分析
    • 国別
    • 薬剤クラス別
    • 病原体別
    • 疾患別
    • 作用機序別
    • 流通経路
  • 主要な市場参入企業：強度マッピング
  • 促進要因と抑制要因：影響分析
  • 国レベルの分析・予測
    • GCC諸国の抗生剤耐性市場
    • トルコの抗生剤耐性市場
    • 南アフリカの抗生剤耐性市場
    • 北アフリカの抗生剤耐性市場

第21章 市場構造分析

  • 市場分析：企業層別
  • 主要企業の市場シェア分析
  • 市場プレゼンス分析

第22章 競合分析

  • 競合ダッシュボード
  • 競合ベンチマーク
  • 競合の詳細
    • Merck KgaA
    • Bio-Rad Laboratories, Inc.
    • Takara Bio, Inc.
    • QIAGEN N.V.
    • Pall Corporation
    • Eppendorf Corporate
    • Tarsons Products PVT. LTD.
    • Applied Biological Materials Inc.
    • Greiner AG
    • Brooks Life Sciences
    • Corning Incorporated
    • Cytiva
    • PerkinElmer

第23章 前提条件と頭字語

第24章 調査手法

図表

List of Tables

  • Table 01: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 02: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 03: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 04: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 05: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 06: Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Region
  • Table 07: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 08: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 09: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 10: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 11: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 12: North America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 13: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 14: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 15: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 16: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 17: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 18: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 19: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 20: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 21: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 22: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 23: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 24: Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 25: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 26: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 27: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 28: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 29: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 30: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 31: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 32: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 33: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 34: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 35: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 36: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 37: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 38: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 39: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 40: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 41: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 42: Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel
  • Table 43: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Country
  • Table 44: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis 2015-2022 and Forecast 2023-2033, by Drug Class
  • Table 45: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Pathogen
  • Table 46: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Disease
  • Table 47: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Mechanism of Action
  • Table 48: Middle East & Africa Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Distribution channel

List of Figures

  • Figure 01: Global Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 02: Global Antibiotic Resistance Market Forecast & Y-o-Y Growth, 2023-2033
  • Figure 03: Global Antibiotic Resistance Market Absolute $ Opportunity (US$ Mn) Analysis, 2022-2033
  • Figure 04: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Drug Class
  • Figure 05: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Drug Class
  • Figure 06: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Drug Class
  • Figure 07: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Pathogen
  • Figure 08: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Pathogen
  • Figure 09: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Pathogen
  • Figure 10: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Disease
  • Figure 11: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Disease
  • Figure 12: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Disease
  • Figure 13: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Mechanism of Action
  • Figure 14: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Mechanism of Action
  • Figure 15: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Mechanism of Action
  • Figure 16: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Distribution channel
  • Figure 17: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Distribution channel
  • Figure 18: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Distribution channel
  • Figure 19: Global Antibiotic Resistance Market Value Share (%) Analysis 2023 and 2033, by Region
  • Figure 20: Global Antibiotic Resistance Market Y-o-Y Growth (%) Analysis 2022-2033, by Region
  • Figure 21: Global Antibiotic Resistance Market Attractiveness Analysis 2023-2033, by Region
  • Figure 22: North America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 23: North America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 24: North America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 25: North America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 26: North America Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 27: North America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 28: North America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 29: North America Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 30: North America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 31: North America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 32: North America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 33: North America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 34: North America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 35: North America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 36: U.S. Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 37: Global Vs. U.S. Growth Comparison, 2022 - 2033
  • Figure 38: U.S. Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 39: U.S. Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 40: U.S. Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 41: U.S. Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 42: U.S. Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 43: Canada Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 44: Global Vs. Canada. Growth Comparison, 2022 - 2033
  • Figure 45: Canada Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 46: Canada Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 47: Canada Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 48: Canada Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 49: Canada Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 50: Latin America Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 51: Latin America Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 52: Latin America Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 53: Latin America Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 54: Latin America Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 55: Latin America Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 56: Latin America Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 57: Latin America Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 58: Latin America Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 59: Latin America Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 60: Latin America Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 61: Latin America Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 62: Latin America Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 63: Latin America Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 64: Mexico Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 65: Global Vs Mexico Growth Comparison, 2022 - 2033
  • Figure 66: Mexico Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 67: Mexico Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 68: Mexico Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 69: Mexico Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 70: Mexico Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 71: Brazil Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 72: Global Vs. Brazil. Growth Comparison, 2022 - 2033
  • Figure 73: Brazil Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 74: Brazil Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 75: Brazil Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 76: Brazil Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 77: Brazil Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 78: Argentina Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 79: Global Vs Argentina Growth Comparison, 2022 - 2033
  • Figure 80: Argentina Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 81: Argentina Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 82: Argentina Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 83: Argentina Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 84: Argentina Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 85: Europe Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 86: Europe Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 87: Europe Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 88: Europe Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 89: Europe Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 90: Europe Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 91: Europe Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 92: Europe Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 93: Europe Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 94: Europe Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 95: Europe Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 96: Europe Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 97: Europe Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 98: Europe Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 99: UK Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 100: Global Vs. UK Growth Comparison, 2022 - 2033
  • Figure 101: UK Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 102: UK Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 103: UK Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 104: UK Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 105: UK Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 106: Germany Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 107: Global Vs. Germany Growth Comparison, 2022 - 2033
  • Figure 108: Germany Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 109: Germany Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 110: Germany Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 111: Germany Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 112: Germany Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 113: Italy Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 114: Global Vs. Italy Growth Comparison, 2022 - 2033
  • Figure 115: Italy Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 116: Italy Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 117: Italy Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 118: Italy Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 119: Italy Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 120: France Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 121: Global Vs France Growth Comparison, 2022 - 2033
  • Figure 122: France Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 123: France Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 124: France Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 125: France Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 126: France Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 127: Spain Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 128: Global Vs Spain Growth Comparison, 2022 - 2033
  • Figure 129: Spain Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 130: Spain Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 131: Spain Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 132: Spain Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 133: Spain Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 134: Russia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 135: Global Vs Russia Growth Comparison, 2022 - 2033
  • Figure 136: Russia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 137: Russia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 138: Russia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 139: Russia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 140: Russia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 141: BENELUX Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 142: Global Vs BENELUX Growth Comparison, 2022 - 2033
  • Figure 143: BENELUX Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 144: BENELUX Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 145: BENELUX Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 146: BENELUX Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 147: BENELUX Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 148: East Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 149: East Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 150: East Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 151: East Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 152: East Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 153: East Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 154: East Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 155: East Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 156: East Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 157: East Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 158: East Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 159: East Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 160: East Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 161: East Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 162: China Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 163: Global Vs. China Growth Comparison, 2022 - 2033
  • Figure 164: China Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 165: China Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 166: China Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 167: China Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 168: China Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 169: Japan Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 170: Global Vs. Japan Growth Comparison, 2022 - 2033
  • Figure 171: Japan Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 172: Japan Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 173: Japan Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 174: Japan Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 175: Japan Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 176: South Korea Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 177: Global Vs South Korea Growth Comparison, 2022 - 2033
  • Figure 178: South Korea Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 179: South Korea Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 180: South Korea Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 181: South Korea Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 182: South Korea Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 183: South Asia Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 184: South Asia Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 185: South Asia Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 186: South Asia Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 187: South Asia Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 188: South Asia Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 189: South Asia Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 190: South Asia Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 191: South Asia Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 192: South Asia Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 193: South Asia Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 194: South Asia Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 195: South Asia Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 196: South Asia Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 197: India Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 198: Global Vs. India Growth Comparison, 2022 - 2033
  • Figure 199: India Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 200: India Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 201: India Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 202: India Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 203: India Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 204: Indonesia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 205: Global Vs. Indonesia Growth Comparison, 2022 - 2033
  • Figure 206: Indonesia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 207: Indonesia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 208: Indonesia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 209: Indonesia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 210: Indonesia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 211: Malaysia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 212: Global Vs. Malaysia Growth Comparison, 2022 - 2033
  • Figure 213: Malaysia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 214: Malaysia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 215: Malaysia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 216: Malaysia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 217: Malaysia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 218: Thailand Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 219: Global Vs. Thailand Growth Comparison, 2022 - 2033
  • Figure 220: Thailand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 221: Thailand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 222: Thailand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 223: Thailand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 224: Thailand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 225: Oceania Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 226: Oceania Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 227: Oceania Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 228: Oceania Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 229: Oceania Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 230: Oceania Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 231: Oceania Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 232: Oceania Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 233: Oceania Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 234: Oceania Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 235: Oceania Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 236: Oceania Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 237: Oceania Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 238: Oceania Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 239: Australia Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 240: Global Vs. Australia Growth Comparison, 2022 - 2033
  • Figure 241: Australia Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 242: Australia Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 243: Australia Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 244: Australia Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 245: Australia Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 246: New Zealand Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 247: Global Vs New Zealand Growth Comparison, 2022 - 2033
  • Figure 248: New Zealand Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 249: New Zealand Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 250: New Zealand Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 251: New Zealand Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 252: New Zealand Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 253: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Analysis, 2015-2022
  • Figure 254: Middle East & Africa Antibiotic Resistance Market Value (US$ Mn) Forecast, 2023-2033
  • Figure 255: Middle East & Africa Antibiotic Resistance Market Value Share, by Drug Class (2023 E)
  • Figure 256: Middle East & Africa Antibiotic Resistance Market Value Share, by Pathogen (2023 E)
  • Figure 257: Middle East & Africa Antibiotic Resistance Market Value Share, by Disease (2023 E)
  • Figure 258: Middle East & Africa Antibiotic Resistance Market Value Share, by Mechanism of Action (2023 E)
  • Figure 259: Middle East & Africa Antibiotic Resistance Market Value Share, by Distribution channel (2023 E)
  • Figure 260: Middle East & Africa Antibiotic Resistance Market Value Share, by Country (2023 E)
  • Figure 261: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Drug Class, 2023-2033
  • Figure 262: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Pathogen, 2023-2033
  • Figure 263: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Disease, 2023-2033
  • Figure 264: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Mechanism of Action, 2023-2033
  • Figure 265: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Distribution channel, 2023-2033
  • Figure 266: Middle East & Africa Antibiotic Resistance Market Attractiveness Analysis by Country, 2023-2033
  • Figure 267: GCC Countries Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 268: Global Vs GCC Countries Growth Comparison, 2022 - 2033
  • Figure 269: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 270: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 271: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 272: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 273: GCC Countries Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 274: Turkey Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 275: Global Vs. Turkey Growth Comparison, 2022 - 2033
  • Figure 276: Turkey Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 277: Turkey Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 278: Turkey Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 279: Turkey Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 280: Turkey Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 281: South Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 282: Global Vs. South Africa Growth Comparison, 2022 - 2033
  • Figure 283: South Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 284: South Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 285: South Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 286: South Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 287: South Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
  • Figure 288: North Africa Antibiotic Resistance Market Value Proportion Analysis, 2022
  • Figure 289: Global Vs North Africa Growth Comparison, 2022 - 2033
  • Figure 290: North Africa Antibiotic Resistance Market Share Analysis (%) by Drug Class, 2022 & 2033
  • Figure 291: North Africa Antibiotic Resistance Market Share Analysis (%) by Pathogen, 2022 & 2033
  • Figure 292: North Africa Antibiotic Resistance Market Share Analysis (%) by Disease, 2022 & 2033
  • Figure 293: North Africa Antibiotic Resistance Market Share Analysis (%) by Mechanism of Action, 2022 & 2033
  • Figure 294: North Africa Antibiotic Resistance Market Share Analysis (%) by Distribution channel, 2022 & 2033
目次
Product Code: PMRREP27895

Antibiotic Resistance Market: Scope of the Report

The latest publication by Persistence Market Research on the global antibiotic resistance market evaluates the opportunities and current market landscape and provides detailed analysis and updates about corresponding sections affecting the market. The study offers detailed insights into current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023-2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for antibiotic resistance products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the antibiotic resistance market. Insights and information presented in this Persistence Market Research study can be leveraged by shareholders in the antibiotic resistance market, industry experts, investors, researchers, and reporters, as well as business enthusiasts.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the antibiotic resistance market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research's study on the antibiotic resistance market offers information divided into six important segments -drug class, pathogen, disease, mechanism of action, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug Class

Beta Lactum Antibiotic

Cephalosporins

Quinolones Antibiotics

Macrolide Antibiotics

Tetracyclines

Oxazolidinones

Others

Pathogen

Staphylococcus aureus

Streptococcus pneumonia

Neisseria gonorrhoeae

Enterococcus faecium

Escherichia coli

Klebsiella Pneumonia

Shigella

Clostridium difficile

Others

Disease

Community Acquired Bacterial Pneumonia (CABP)

Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)

Complicated Urinary Tract Infections (CUTI)

Complicated Intra-Abdominal Infections (CIAI)

Blood Stream Infections (BSI)

Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)

Acute Bacterial Skin and Skin Structure Infections (ABSSSI)

Drug Resistant Gonorrhoeae

Mechanism of Action

Cell Wall Synthesis Inhibitors

Protein Synthesis Inhibitors

DNA Synthesis Inhibitors

RNA Synthesis Inhibitors

Others

Distribution channel

Hospitals Pharmacies

Retail Pharmacies

Online Pharmacies

Region

North America

Latin America

Europe

East Asia

South Asia

Oceania

Middle East and Africa

Key Questions Answered in Report:

Which regions will continue to remain the most profitable markets for antibiotic resistance over the coming years?

How will changing trends impact the market?

How has the COVID-19 crisis impacted market growth?

How can market players capture the low-hanging opportunities in developed regions?

What are the strategies of stakeholders in the market to shape their position in this landscape?

What are the restraining factors that investors need to be aware of and might tackle while investing in the market?

What are the developmental trends that will impact the market?

How can companies in the antibiotic resistance market avail themselves of the growth opportunities in developed and emerging sectors?

Research Methodology

In Persistence Market Research's study, a unique research methodology is utilized to conduct extensive research on the growth of the antibiotic resistance market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market and makes Persistence Market Research's projections on the growth prospects of the antibiotic resistance market are more accurate and reliable.

Table of Contents

1. Executive Summary

  • 1.1. Global Market Outlook
  • 1.2. Demand Side Trends
  • 1.3. Supply-Side Trends
  • 1.4. Analysis and Recommendations

2. Market Overview

  • 2.1. Market Coverage / Taxonomy
  • 2.2. Market Definition / Scope / Limitations
  • 2.3. Inclusion and Exclusion

3. Key Market Trends

  • 3.1. Key Trends Impacting the Market
  • 3.2. Product Innovation / Development Trends

4. Key Success Factors

  • 4.1. Disease Epidemiology
  • 4.2. Product Adoption Analysis
  • 4.3. Product USPs Analysis
  • 4.4. Key Strategies Adopted by Manufactures
  • 4.5. Pipeline Assessment
  • 4.6. PESTLE Analysis
  • 4.7. Porters Analysis
  • 4.8. Regulatory Scenario

5. Market Background

  • 5.1. Macro-Economic Factors
    • 5.1.1. Global GDP Outlook
    • 5.1.2. Global Biopharmaceutical Outlook
  • 5.2. Forecast Factors - Relevance & Impact
    • 5.2.1. Top Companies Historical Growth
    • 5.2.2. Prevalence of Hospital-Acquired Infections
    • 5.2.3. Key Regulations
    • 5.2.4. Government Funding
    • 5.2.5. Reimbursement Policy
    • 5.2.6. Growing R&D Practices
    • 5.2.7. Incidence of Bacterial Infections
    • 5.2.8. New Product Launches and Approvals
  • 5.3. Market Dynamics
    • 5.3.1. Drivers
    • 5.3.2. Restraints
    • 5.3.3. Opportunity Analysis

6. COVID-19 Crisis

  • 6.1. 2022 Market Scenario
  • 6.2. COVID-19 and Impact Analysis
    • 6.2.1. By Drug Class
    • 6.2.2. By Pathogen
    • 6.2.3. By Disease
    • 6.2.4. By Mechanism of Action
    • 6.2.5. By Distribution channel
    • 6.2.6. By Region

7. Global Antibiotic Resistance Market Demand (in Value or Size in US$ Mn) Analysis 2015-2022 and Forecast, 2023-2033

  • 7.1. Historical Market Value (US$ Mn) Analysis, 2015-2022
  • 7.2. Current and Future Market Value (US$ Mn) Projections, 2023-2033
    • 7.2.1. Y-o-Y Growth Trend Analysis
    • 7.2.2. Absolute $ Opportunity Analysis

8. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Drug Class

  • 8.1. Introduction / Key Findings
  • 8.2. Historical Market Size (US$ Mn) Analysis By Drug Class, 2015-2022
  • 8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Drug Class, 2023-2033
    • 8.3.1. Beta Lactum Antibiotic
    • 8.3.2. Cephalosporins
    • 8.3.3. Quinolones Antibiotics
    • 8.3.4. Macrolide Antibiotics
    • 8.3.5. Tetracyclines
    • 8.3.6. Oxazolidinones
    • 8.3.7. Others
  • 8.4. Market Attractiveness Analysis By Drug Class

9. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Pathogen

  • 9.1. Introduction / Key Findings
  • 9.2. Historical Market Size (US$ Mn) Analysis By Pathogen, 2015-2022
  • 9.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Pathogen, 2023-2033
    • 9.3.1. Staphylococcus aureus
    • 9.3.2. Streptococcus pneumonia
    • 9.3.3. Neisseria gonorrhoeae
    • 9.3.4. Enterococcus faecium
    • 9.3.5. Escherichia coli
    • 9.3.6. Klebsiella Pneumonia
    • 9.3.7. Shigella
    • 9.3.8. Clostridium difficile
    • 9.3.9. Others
  • 9.4. Market Attractiveness Analysis By Pathogen

10. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Disease

  • 10.1. Introduction / Key Findings
  • 10.2. Historical Market Size (US$ Mn) Analysis By Disease, 2015-2022
  • 10.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Disease, 2023-2033
    • 10.3.1. Community Acquired Bacterial Pneumonia (CABP)
    • 10.3.2. Hopitals Acquired Bacterial Pneumonia/ Ventilator (HABP/VABP)
    • 10.3.3. Complicated Urinary Tract Infections (CUTI)
    • 10.3.4. Complicated Intra-Abdominal Infections (CIAI)
    • 10.3.5. Blood Stream Infections (BSI)
    • 10.3.6. Abdominal Infection and Diarohhea (Clostridium difficile infections (CDI) & Shigella)
    • 10.3.7. Acute Bacterial Skin and Skin Structure Infections (ABSSSI)
    • 10.3.8. Drug Resistant Gonorrhoeae
  • 10.4. Market Attractiveness Analysis By Disease

11. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Mechanism of Action

  • 11.1. Introduction / Key Findings
  • 11.2. Historical Market Size (US$ Mn) Analysis By Mechanism of Action, 2015-2022
  • 11.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Mechanism of Action, 2023-2033
    • 11.3.1. Cell Wall Synthesis Inhibitors
    • 11.3.2. Protein Synthesis Inhibitors
    • 11.3.3. DNA Synthesis Inhibitors
    • 11.3.4. RNA Synthesis Inhibitors
    • 11.3.5. Others
  • 11.4. Market Attractiveness Analysis By Mechanism of Action

12. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, By Distribution channel

  • 12.1. Introduction / Key Findings
  • 12.2. Historical Market Size (US$ Mn) Analysis By Distribution channel, 2015-2022
  • 12.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution channel, 2023-2033
    • 12.3.1. Hospitals Pharmacies
    • 12.3.2. Retail Pharmacies
    • 12.3.3. Online Pharmacies
  • 12.4. Market Attractiveness Analysis By Distribution channel

13. Global Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033, by Region

  • 13.1. Introduction
  • 13.2. Historical Market Size (US$ Mn) Analysis By Region, 2015-2022
  • 13.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2023-2033
    • 13.3.1. North America
    • 13.3.2. Latin America
    • 13.3.3. Europe
    • 13.3.4. East Asia
    • 13.3.5. South Asia
    • 13.3.6. Oceania
    • 13.3.7. Middle East and Africa (MEA)
  • 13.4. Market Attractiveness Analysis By Region

14. North America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 14.1. Introduction
  • 14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 14.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 14.3.1. By Country
      • 14.3.1.1. U.S.
      • 14.3.1.2. Canada
    • 14.3.2. By Drug Class
    • 14.3.3. By Pathogen
    • 14.3.4. By Disease
    • 14.3.5. By Mechanism of Action
    • 14.3.6. Distribution channel
  • 14.4. Market Attractiveness Analysis
    • 14.4.1. By Country
    • 14.4.2. By Drug Class
    • 14.4.3. By Pathogen
    • 14.4.4. By Disease
    • 14.4.5. By Mechanism of Action
    • 14.4.6. Distribution channel
  • 14.5. Key Market Participants - Intensity Mapping
  • 14.6. Drivers and Restraints - Impact Analysis
  • 14.7. Country Level Analysis & Forecast
    • 14.7.1. U.S. Antibiotic Resistance Market
      • 14.7.1.1. Introduction
      • 14.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.1.2.1. By Drug Class
        • 14.7.1.2.2. By Pathogen
        • 14.7.1.2.3. By Disease
        • 14.7.1.2.4. By Mechanism of Action
        • 14.7.1.2.5. Distribution channel
    • 14.7.2. Canada Antibiotic Resistance Market
      • 14.7.2.1. Introduction
      • 14.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 14.7.2.2.1. By Drug Class
        • 14.7.2.2.2. By Pathogen
        • 14.7.2.2.3. By Disease
        • 14.7.2.2.4. By Mechanism of Action
        • 14.7.2.2.5. Distribution channel

15. Latin America Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 15.1. Introduction
  • 15.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 15.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 15.3.1. By Country
      • 15.3.1.1. Brazil
      • 15.3.1.2. Mexico
      • 15.3.1.3. Rest of Latin America
    • 15.3.2. By Drug Class
    • 15.3.3. By Pathogen
    • 15.3.4. By Disease
    • 15.3.5. By Mechanism of Action
    • 15.3.6. Distribution channel
  • 15.4. Market Attractiveness Analysis
    • 15.4.1. By Country
    • 15.4.2. By Drug Class
    • 15.4.3. By Pathogen
    • 15.4.4. By Disease
    • 15.4.5. By Mechanism of Action
    • 15.4.6. Distribution channel
  • 15.5. Key Market Participants - Intensity Mapping
  • 15.6. Drivers and Restraints - Impact Analysis
  • 15.7. Country Level Analysis & Forecast
    • 15.7.1. Brazil Antibiotic Resistance Market
      • 15.7.1.1. Introduction
      • 15.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.1.2.1. By Drug Class
        • 15.7.1.2.2. By Pathogen
        • 15.7.1.2.3. By Disease
        • 15.7.1.2.4. By Mechanism of Action
        • 15.7.1.2.5. Distribution channel
    • 15.7.2. Argentina Antibiotic Resistance Market
      • 15.7.2.1. Introduction
      • 15.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.2.2.1. By Drug Class
        • 15.7.2.2.2. By Pathogen
        • 15.7.2.2.3. By Disease
        • 15.7.2.2.4. By Mechanism of Action
        • 15.7.2.2.5. Distribution channel
    • 15.7.3. Mexico Antibiotic Resistance Market
      • 15.7.3.1. Introduction
      • 15.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 15.7.3.2.1. By Drug Class
        • 15.7.3.2.2. By Pathogen
        • 15.7.3.2.3. By Disease
        • 15.7.3.2.4. By Mechanism of Action
        • 15.7.3.2.5. Distribution channel

16. Europe Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 16.1. Introduction
  • 16.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 16.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 16.3.1. By Country
      • 16.3.1.1. Germany
      • 16.3.1.2. Italy
      • 16.3.1.3. France
      • 16.3.1.4. U.K.
      • 16.3.1.5. Spain
      • 16.3.1.6. BENELUX
      • 16.3.1.7. Russia
      • 16.3.1.8. Rest of Europe
    • 16.3.2. By Drug Class
    • 16.3.3. By Pathogen
    • 16.3.4. By Disease
    • 16.3.5. By Mechanism of Action
    • 16.3.6. Distribution channel
  • 16.4. Market Attractiveness Analysis
    • 16.4.1. By Country
    • 16.4.2. By Drug Class
    • 16.4.3. By Pathogen
    • 16.4.4. By Disease
    • 16.4.5. By Mechanism of Action
    • 16.4.6. Distribution channel
  • 16.5. Key Market Participants - Intensity Mapping
  • 16.6. Drivers and Restraints - Impact Analysis
  • 16.7. Country Level Analysis & Forecast
    • 16.7.1. Germany Antibiotic Resistance Market
      • 16.7.1.1. Introduction
      • 16.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.1.2.1. By Drug Class
        • 16.7.1.2.2. By Pathogen
        • 16.7.1.2.3. By Disease
        • 16.7.1.2.4. By Mechanism of Action
        • 16.7.1.2.5. Distribution channel
    • 16.7.2. France Antibiotic Resistance Market
      • 16.7.2.1. Introduction
      • 16.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.2.2.1. By Drug Class
        • 16.7.2.2.2. By Pathogen
        • 16.7.2.2.3. By Disease
        • 16.7.2.2.4. By Mechanism of Action
        • 16.7.2.2.5. Distribution channel
    • 16.7.3. Italy Antibiotic Resistance Market
      • 16.7.3.1. Introduction
      • 16.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.3.2.1. By Drug Class
        • 16.7.3.2.2. By Pathogen
        • 16.7.3.2.3. By Disease
        • 16.7.3.2.4. By Mechanism of Action
        • 16.7.3.2.5. Distribution channel
    • 16.7.4. Spain Antibiotic Resistance Market
      • 16.7.4.1. Introduction
      • 16.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.4.2.1. By Drug Class
        • 16.7.4.2.2. By Pathogen
        • 16.7.4.2.3. By Disease
        • 16.7.4.2.4. By Mechanism of Action
        • 16.7.4.2.5. Distribution channel
    • 16.7.5. U.K. Antibiotic Resistance Market
      • 16.7.5.1. Introduction
      • 16.7.5.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.5.2.1. By Drug Class
        • 16.7.5.2.2. By Pathogen
        • 16.7.5.2.3. By Disease
        • 16.7.5.2.4. By Mechanism of Action
        • 16.7.5.2.5. Distribution channel
    • 16.7.6. BENELUX Union Antibiotic Resistance Market
      • 16.7.6.1. Introduction
      • 16.7.6.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.6.2.1. By Drug Class
        • 16.7.6.2.2. By Pathogen
        • 16.7.6.2.3. By Disease
        • 16.7.6.2.4. By Mechanism of Action
        • 16.7.6.2.5. Distribution channel
    • 16.7.7. Russia Antibiotic Resistance Market
      • 16.7.7.1. Introduction
      • 16.7.7.2. Market Analysis and Forecast by Market Taxonomy
        • 16.7.7.2.1. By Drug Class
        • 16.7.7.2.2. By Pathogen
        • 16.7.7.2.3. By Disease
        • 16.7.7.2.4. By Mechanism of Action
        • 16.7.7.2.5. Distribution channel

17. South Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 17.1. Introduction
  • 17.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 17.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 17.3.1. By Country
      • 17.3.1.1. India
      • 17.3.1.2. Thailand
      • 17.3.1.3. Indonesia
      • 17.3.1.4. Malaysia
      • 17.3.1.5. Rest of South Asia
    • 17.3.2. By Drug Class
    • 17.3.3. By Pathogen
    • 17.3.4. By Disease
    • 17.3.5. By Mechanism of Action
    • 17.3.6. Distribution channel
  • 17.4. Market Attractiveness Analysis
    • 17.4.1. By Country
    • 17.4.2. By Drug Class
    • 17.4.3. By Pathogen
    • 17.4.4. By Disease
    • 17.4.5. By Mechanism of Action
    • 17.4.6. Distribution channel
  • 17.5. Key Market Participants - Intensity Mapping
  • 17.6. Drivers and Restraints - Impact Analysis
  • 17.7. Country Level Analysis & Forecast
    • 17.7.1. India Antibiotic Resistance Market
      • 17.7.1.1. Introduction
      • 17.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.1.2.1. By Drug Class
        • 17.7.1.2.2. By Pathogen
        • 17.7.1.2.3. By Disease
        • 17.7.1.2.4. By Mechanism of Action
        • 17.7.1.2.5. Distribution channel
    • 17.7.2. Indonesia Antibiotic Resistance Market
      • 17.7.2.1. Introduction
      • 17.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.2.2.1. By Drug Class
        • 17.7.2.2.2. By Pathogen
        • 17.7.2.2.3. By Disease
        • 17.7.2.2.4. By Mechanism of Action
        • 17.7.2.2.5. Distribution channel
    • 17.7.3. Malaysia Antibiotic Resistance Market
      • 17.7.3.1. Introduction
      • 17.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.3.2.1. By Drug Class
        • 17.7.3.2.2. By Pathogen
        • 17.7.3.2.3. By Disease
        • 17.7.3.2.4. By Mechanism of Action
        • 17.7.3.2.5. Distribution channel
    • 17.7.4. Thailand Antibiotic Resistance Market
      • 17.7.4.1. Introduction
      • 17.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 17.7.4.2.1. By Drug Class
        • 17.7.4.2.2. By Pathogen
        • 17.7.4.2.3. By Disease
        • 17.7.4.2.4. By Mechanism of Action
        • 17.7.4.2.5. Distribution channel

18. East Asia Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 18.1. Introduction
  • 18.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 18.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 18.3.1. By Country
      • 18.3.1.1. China
      • 18.3.1.2. Japan
      • 18.3.1.3. South Korea
    • 18.3.2. By Drug Class
    • 18.3.3. By Pathogen
    • 18.3.4. By Disease
    • 18.3.5. By Mechanism of Action
    • 18.3.6. Distribution channel
  • 18.4. Market Attractiveness Analysis
    • 18.4.1. By Country
    • 18.4.2. By Drug Class
    • 18.4.3. By Pathogen
    • 18.4.4. By Disease
    • 18.4.5. By Mechanism of Action
    • 18.4.6. Distribution channel
  • 18.5. Key Market Participants - Intensity Mapping
  • 18.6. Drivers and Restraints - Impact Analysis
  • 18.7. Country Level Analysis & Forecast
    • 18.7.1. China Antibiotic Resistance Market
      • 18.7.1.1. Introduction
      • 18.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.1.2.1. By Drug Class
        • 18.7.1.2.2. By Pathogen
        • 18.7.1.2.3. By Disease
        • 18.7.1.2.4. By Mechanism of Action
        • 18.7.1.2.5. Distribution channel
    • 18.7.2. Japan Antibiotic Resistance Market
      • 18.7.2.1. Introduction
      • 18.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.2.2.1. By Drug Class
        • 18.7.2.2.2. By Pathogen
        • 18.7.2.2.3. By Disease
        • 18.7.2.2.4. By Mechanism of Action
        • 18.7.2.2.5. Distribution channel
    • 18.7.3. South Korea Antibiotic Resistance Market
      • 18.7.3.1. Introduction
      • 18.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 18.7.3.2.1. By Drug Class
        • 18.7.3.2.2. By Pathogen
        • 18.7.3.2.3. By Disease
        • 18.7.3.2.4. By Mechanism of Action
        • 18.7.3.2.5. Distribution channel

19. Oceania Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 19.1. Introduction
  • 19.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 19.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 19.3.1. By Country
      • 19.3.1.1. Australia
      • 19.3.1.2. New Zealand
    • 19.3.2. By Drug Class
    • 19.3.3. By Pathogen
    • 19.3.4. By Disease
    • 19.3.5. By Mechanism of Action
    • 19.3.6. Distribution channel
  • 19.4. Market Attractiveness Analysis
    • 19.4.1. By Country
    • 19.4.2. By Drug Class
    • 19.4.3. By Pathogen
    • 19.4.4. By Disease
    • 19.4.5. By Mechanism of Action
    • 19.4.6. Distribution channel
  • 19.5. Key Market Participants - Intensity Mapping
  • 19.6. Drivers and Restraints - Impact Analysis
  • 19.7. Country Level Analysis & Forecast
    • 19.7.1. Australia Antibiotic Resistance Market
      • 19.7.1.1. Introduction
      • 19.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.1.2.1. By Drug Class
        • 19.7.1.2.2. By Pathogen
        • 19.7.1.2.3. By Disease
        • 19.7.1.2.4. By Mechanism of Action
        • 19.7.1.2.5. Distribution channel
    • 19.7.2. New Zealand Antibiotic Resistance Market
      • 19.7.2.1. Introduction
      • 19.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 19.7.2.2.1. By Drug Class
        • 19.7.2.2.2. By Pathogen
        • 19.7.2.2.3. By Disease
        • 19.7.2.2.4. By Mechanism of Action
        • 19.7.2.2.5. Distribution channel

20. Middle East and Africa (MEA) Antibiotic Resistance Market Analysis 2015-2022 and Forecast 2023-2033

  • 20.1. Introduction
  • 20.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2015-2022
  • 20.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Market Taxonomy, 2023-2033
    • 20.3.1. By Country
      • 20.3.1.1. GCC Countries
      • 20.3.1.2. Turkey
      • 20.3.1.3. North Africa
      • 20.3.1.4. South Africa
      • 20.3.1.5. Rest of Middle East and Africa
    • 20.3.2. By Drug Class
    • 20.3.3. By Pathogen
    • 20.3.4. By Disease
    • 20.3.5. By Mechanism of Action
    • 20.3.6. Distribution channel
  • 20.4. Market Attractiveness Analysis
    • 20.4.1. By Country
    • 20.4.2. By Drug Class
    • 20.4.3. By Pathogen
    • 20.4.4. By Disease
    • 20.4.5. By Mechanism of Action
    • 20.4.6. Distribution channel
  • 20.5. Key Market Participants - Intensity Mapping
  • 20.6. Drivers and Restraints - Impact Analysis
  • 20.7. Country Level Analysis & Forecast
    • 20.7.1. GCC Countries Antibiotic Resistance Market
      • 20.7.1.1. Introduction
      • 20.7.1.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.1.2.1. By Drug Class
        • 20.7.1.2.2. By Pathogen
        • 20.7.1.2.3. By Disease
        • 20.7.1.2.4. By Mechanism of Action
        • 20.7.1.2.5. Distribution channel
    • 20.7.2. Turkey Antibiotic Resistance Market
      • 20.7.2.1. Introduction
      • 20.7.2.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.2.2.1. By Drug Class
        • 20.7.2.2.2. By Pathogen
        • 20.7.2.2.3. By Disease
        • 20.7.2.2.4. By Mechanism of Action
        • 20.7.2.2.5. Distribution channel
    • 20.7.3. South Africa Antibiotic Resistance Market
      • 20.7.3.1. Introduction
      • 20.7.3.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.3.2.1. By Drug Class
        • 20.7.3.2.2. By Pathogen
        • 20.7.3.2.3. By Disease
        • 20.7.3.2.4. By Mechanism of Action
        • 20.7.3.2.5. Distribution channel
    • 20.7.4. North Africa Antibiotic Resistance Market
      • 20.7.4.1. Introduction
      • 20.7.4.2. Market Analysis and Forecast by Market Taxonomy
        • 20.7.4.2.1. By Drug Class
        • 20.7.4.2.2. By Pathogen
        • 20.7.4.2.3. By Disease
        • 20.7.4.2.4. By Mechanism of Action
        • 20.7.4.2.5. Distribution channel

21. Market Structure Analysis

  • 21.1. Market Analysis by Tier of Companies
  • 21.2. Market Share Analysis of Top Players
  • 21.3. Market Presence Analysis

22. Competition Analysis

  • 22.1. Competition Dashboard
  • 22.2. Competition Benchmarking
  • 22.3. Competition Deep Dive

        22.3.1.Thermo Fisher Scientific, Inc.

      • 22.3.1.1. Overview
      • 22.3.1.2. Product Portfolio
      • 22.3.1.3. Sales Footprint
      • 22.3.1.4. Key Development
      • 22.3.1.5. SWOT Analysis
      • 22.3.1.6. Strategy Overview
        • 22.3.1.6.1. Marketing Strategy
        • 22.3.1.6.2. Product Strategy
        • 22.3.1.6.3. Channel Strategy
    • 22.3.2. Merck KgaA
      • 22.3.2.1. Overview
      • 22.3.2.2. Product Portfolio
      • 22.3.2.3. Sales Footprint
      • 22.3.2.4. Key Development
      • 22.3.2.5. SWOT Analysis
      • 22.3.2.6. Strategy Overview
        • 22.3.2.6.1. Marketing Strategy
        • 22.3.2.6.2. Product Strategy
        • 22.3.2.6.3. Channel Strategy
    • 22.3.3. Bio-Rad Laboratories, Inc.
      • 22.3.3.1. Overview
      • 22.3.3.2. Product Portfolio
      • 22.3.3.3. Sales Footprint
      • 22.3.3.4. Key Development
      • 22.3.3.5. SWOT Analysis
      • 22.3.3.6. Strategy Overview
        • 22.3.3.6.1. Marketing Strategy
        • 22.3.3.6.2. Product Strategy
        • 22.3.3.6.3. Channel Strategy
    • 22.3.4. Takara Bio, Inc.
      • 22.3.4.1. Overview
      • 22.3.4.2. Product Portfolio
      • 22.3.4.3. Sales Footprint
      • 22.3.4.4. Key Development
      • 22.3.4.5. SWOT Analysis
      • 22.3.4.6. Strategy Overview
        • 22.3.4.6.1. Marketing Strategy
        • 22.3.4.6.2. Product Strategy
        • 22.3.4.6.3. Channel Strategy
    • 22.3.5. QIAGEN N.V.
      • 22.3.5.1. Overview
      • 22.3.5.2. Product Portfolio
      • 22.3.5.3. Sales Footprint
      • 22.3.5.4. Key Development
      • 22.3.5.5. SWOT Analysis
      • 22.3.5.6. Strategy Overview
        • 22.3.5.6.1. Marketing Strategy
        • 22.3.5.6.2. Product Strategy
        • 22.3.5.6.3. Channel Strategy
    • 22.3.6. Pall Corporation
      • 22.3.6.1. Overview
      • 22.3.6.2. Product Portfolio
      • 22.3.6.3. Sales Footprint
      • 22.3.6.4. Key Development
      • 22.3.6.5. SWOT Analysis
      • 22.3.6.6. Strategy Overview
        • 22.3.6.6.1. Marketing Strategy
        • 22.3.6.6.2. Product Strategy
        • 22.3.6.6.3. Channel Strategy
    • 22.3.7. Eppendorf Corporate
      • 22.3.7.1. Overview
      • 22.3.7.2. Product Portfolio
      • 22.3.7.3. Sales Footprint
      • 22.3.7.4. Key Development
      • 22.3.7.5. SWOT Analysis
      • 22.3.7.6. Strategy Overview
        • 22.3.7.6.1. Marketing Strategy
        • 22.3.7.6.2. Product Strategy
        • 22.3.7.6.3. Channel Strategy
    • 22.3.8. Tarsons Products PVT. LTD.
      • 22.3.8.1. Overview
      • 22.3.8.2. Product Portfolio
      • 22.3.8.3. Sales Footprint
      • 22.3.8.4. Key Development
      • 22.3.8.5. SWOT Analysis
      • 22.3.8.6. Strategy Overview
        • 22.3.8.6.1. Marketing Strategy
        • 22.3.8.6.2. Product Strategy
        • 22.3.8.6.3. Channel Strategy
    • 22.3.9. Applied Biological Materials Inc.
      • 22.3.9.1. Overview
      • 22.3.9.2. Product Portfolio
      • 22.3.9.3. Sales Footprint
      • 22.3.9.4. Key Development
      • 22.3.9.5. SWOT Analysis
      • 22.3.9.6. Strategy Overview
        • 22.3.9.6.1. Marketing Strategy
        • 22.3.9.6.2. Product Strategy
        • 22.3.9.6.3. Channel Strategy
    • 22.3.10. Greiner AG
      • 22.3.10.1. Overview
      • 22.3.10.2. Product Portfolio
      • 22.3.10.3. Sales Footprint
      • 22.3.10.4. Key Development
      • 22.3.10.5. SWOT Analysis
      • 22.3.10.6. Strategy Overview
        • 22.3.10.6.1. Marketing Strategy
        • 22.3.10.6.2. Product Strategy
        • 22.3.10.6.3. Channel Strategy
    • 22.3.11. Brooks Life Sciences
      • 22.3.11.1. Overview
      • 22.3.11.2. Product Portfolio
      • 22.3.11.3. Sales Footprint
      • 22.3.11.4. Key Development
      • 22.3.11.5. SWOT Analysis
      • 22.3.11.6. Strategy Overview
        • 22.3.11.6.1. Marketing Strategy
        • 22.3.11.6.2. Product Strategy
        • 22.3.11.6.3. Channel Strategy
    • 22.3.12. Corning Incorporated
      • 22.3.12.1. Overview
      • 22.3.12.2. Product Portfolio
      • 22.3.12.3. Sales Footprint
      • 22.3.12.4. Key Development
      • 22.3.12.5. SWOT Analysis
      • 22.3.12.6. Strategy Overview
        • 22.3.12.6.1. Marketing Strategy
        • 22.3.12.6.2. Product Strategy
        • 22.3.12.6.3. Channel Strategy
    • 22.3.13. Cytiva
      • 22.3.13.1. Overview
      • 22.3.13.2. Product Portfolio
      • 22.3.13.3. Sales Footprint
      • 22.3.13.4. Key Development
      • 22.3.13.5. SWOT Analysis
      • 22.3.13.6. Strategy Overview
        • 22.3.13.6.1. Marketing Strategy
        • 22.3.13.6.2. Product Strategy
        • 22.3.13.6.3. Channel Strategy
    • 22.3.14. PerkinElmer
      • 22.3.14.1. Overview
      • 22.3.14.2. Product Portfolio
      • 22.3.14.3. Sales Footprint
      • 22.3.14.4. Key Development
      • 22.3.14.5. SWOT Analysis
      • 22.3.14.6. Strategy Overview
        • 22.3.14.6.1. Marketing Strategy
        • 22.3.14.6.2. Product Strategy
        • 22.3.14.6.3. Channel Strategy

23. Assumptions and Acronyms Used

24. Research Methodology